Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer's disease.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31467276.
- Also identified by DOI 10.1038/s41467-019-11813-6 and PMC identifier 6715724.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Impairments in neuronal intracellular calcium (<sub>i</sub>Ca<sup>2+</sup>) handling may contribute to Alzheimer's disease (AD) development. Metabolic dysfunction and progressive neuronal loss are associated with AD progression, and mitochondrial calcium (<sub>m</sub>Ca<sup>2+</sup>) signaling is a key regulator of both of these processes. Here, we report remodeling of the <sub>m</sub>Ca<sup>2+</sup> exchange machinery in the prefrontal cortex of individuals with AD. In the 3xTg-AD mouse model impaired <sub>m</sub>Ca<sup>2+</sup> efflux capacity precedes neuropathology. Neuronal deletion of the mitochondrial Na<sup>+</sup>/Ca<sup>2+</sup> exchanger (NCLX, Slc8b1 gene) accelerated memory decline and increased amyloidosis and tau pathology. Further, genetic rescue of neuronal NCLX in 3xTg-AD mice is sufficient to impede AD-associated pathology and memory loss. We show that <sub>m</sub>Ca<sup>2+</sup> overload contributes to AD progression by promoting superoxide generation, metabolic dysfunction and neuronal cell death. These results provide a link between the calcium dysregulation and metabolic dysfunction hypotheses of AD and suggest <sub>m</sub>Ca<sup>2+</sup> exchange as potential therapeutic target in AD.
Medical subject headings
- Alzheimer Disease
- Calcium
- Disease Progression
- Mitochondria
- Sodium-Calcium Exchanger